-
公开(公告)号：KR1020100010058A
公开(公告)日：2010-01-29
申请号：KR1020100002609
申请日：2010-01-12
Applicant: (주)아모레퍼시픽
Abstract: PURPOSE: A skin external composition containing omega-3 fatty acid is provided to strengthen skin barrier and protect skin from outer harmful environment. CONSTITUTION: A skin external composition contains omega-3 fatty acid as an active ingredient. The omega-3 fatty acid contains skin external formulation in an oil form containing omega-3 fatty acid. The oil containing omega-3 fatty acid is black currant. The omega-3 fatty acid is contained in 0.5-3 weight% of total composition. The skin external composition is used in the form of oil-in-water emulsion formulation.
Abstract translation: 目的：提供含有ω-3脂肪酸的皮肤外用组合物，以增强皮肤屏障，保护皮肤免于外界有害环境。 构成：皮肤外用组合物含有ω-3脂肪酸作为活性成分。 ω-3脂肪酸含有含有ω-3脂肪酸的油形式的皮肤外用制剂。 含有ω-3脂肪酸的油是黑醋栗。 ω-3脂肪酸含量为总组合物的0.5-3重量％。 皮肤外用组合物以水包油乳液制剂的形式使用。
-
公开(公告)号：KR1020080049421A
公开(公告)日：2008-06-04
申请号：KR1020060119947
申请日：2006-11-30
Applicant: (주)아모레퍼시픽
IPC: A61K8/97 , A61K36/488
CPC classification number: A61K8/97 , A61K2800/782 , A61Q19/08 , C12N9/14
Abstract: A composition comprising an extract of Pueraria radix or luteolin is provided to inhibit the decomposition of fibronectin effectively and inhibit the generation of metalloprotease in a skin cell, thereby being used for human body without harm. A composition for inhibiting the expression of cathepsin comprises an extract of Pueraria radix or luteolin as an effective ingredient, wherein the dried weight of the Pueraria radix or luteolin regarding the total composition is 0.0001-5 wt.% and the luteolin is isolated from Aurantii Immatri Pericarpium. Further, the composition is a skin preparation for external use.
Abstract translation: 提供了包含葛根提取物或木犀草素的组合物，以有效抑制纤连蛋白的分解并抑制皮肤细胞中金属蛋白酶的产生，从而被用于人体而不受伤害。 用于抑制组织蛋白酶表达的组合物包含葛根或木犀草素的提取物作为有效成分，其中葛根或木犀草素的干重与总组合物相比为0.0001-5重量％，并且木犀草素从Aurantii Immatri Pericarpium。 此外，组合物是外用皮肤制剂。
-
公开(公告)号：KR1020080011543A
公开(公告)日：2008-02-05
申请号：KR1020060071985
申请日：2006-07-31
Applicant: (주)아모레퍼시픽
CPC classification number: A61K8/35 , A61K8/36 , A61K8/466 , A61K2800/78 , A61Q19/08
Abstract: A cosmetic composition is provided to promote collagen biosynthesis by comprising alpha-ketoglutarate increasing the prolidase activity involving with the supply of proline, a main constituent amino acid of the collagen, together with alpha-lipoic acid increasing the expression of prolyl-4-hydroxylase to make a generated pro-collagen form a right triple helix. A cosmetic composition for improving skin wrinkle comprises 0.001-10 wt.% of alpha-ketoglutarate as an effective ingredient. The composition further comprises 0.001-10 wt.% of alpha-lipoic acid.
Abstract translation: 提供化妆品组合物以通过包含α-酮戊二酸来增加胶原蛋白生物合成，所述α-酮戊二酸增加脯氨酸酶活性，其涉及脯氨酸的供应，胶原的主要成分氨基酸与α-硫辛酸一起增加脯氨酰-4-羟化酶的表达， 使生成的原胶原形成右三重螺旋。 用于改善皮肤皱纹的化妆品组合物包含0.001-10重量％的作为有效成分的α-酮戊二酸。 组合物还包含0.001-10重量％的α-硫辛酸。
-
公开(公告)号：KR100741959B1
公开(公告)日：2007-07-23
申请号：KR1020060021256
申请日：2006-03-07
Applicant: (주)아모레퍼시픽
Abstract: A gel-phase cosmetic composition having thixotropic property during application on the skin by using oil-soluble and water-soluble polymers is provided to serve plentiful use feeling and fresh remaining feeling through the thixotropic phenomenon from gel phase to liquid phase. The gel-phase cosmetic composition having thixotropic property during application on the skin comprises 0.5-10.0 wt.% of oil-soluble polymer such as dimethicone/dimethicone PEG(polyethylene glycol)-10,15 crosspolymer/cyclopentasiloxane, 0.5-10.0 wt.% of methylsiloxane reticular polymer, and 0.01-5.0 wt.% of water-soluble polymer such as ammoniumacryloyldimethyltaurate/vinypyrrolidone copolymer, wherein the cosmetic composition has a formulation selected from male essence, female water cream, essence, solubilizing essence or lotion.
Abstract translation: 提供一种通过使用油溶性和水溶性聚合物在皮肤上施用期间具有触变性的凝胶相化妆品组合物，以通过从凝胶相到液相的触变现象提供丰富的使用感和新鲜的残留感。 在皮肤上施用时具有触变性的凝胶相化妆品组合物包含0.5-10.0重量％的油溶性聚合物如聚二甲基硅氧烷/聚二甲基硅氧烷PEG（聚乙二醇）-10,15交联聚合物/环戊硅氧烷，0.5-10.0重量％ 的甲基硅氧烷网状聚合物和0.01-5.0重量％的水溶性聚合物如氨基丙烯酰基二甲基牛磺酸钠/乙烯基吡咯烷酮共聚物，其中所述化妆品组合物具有选自雄性香精，雌性水性乳霜，香精，增溶香精或乳液的制剂。
-
公开(公告)号：KR1020070002133A
公开(公告)日：2007-01-05
申请号：KR1020050057462
申请日：2005-06-30
Applicant: (주)아모레퍼시픽
Abstract: A skin external composition is provided to increase production of tropoelastin in the skin, and productions of collagen and fibrilin in the dermis layer, so that the composition is useful for skin wrinkle improvement, skin elasticity enhancement, and skin moisturizing increase. The skin external composition for improving skin wrinkle, enhancing skin elasticity and increasing skin moisturizing comprises a mixture containing palmitoylpentapeptide, soybean embryo isoflavone aglycon, extract of Medicago sativa and extract of Iris florenti, wherein the palmitoylpentapeptide is prepared by binding a palmitoyl group to 5 amino acid chain molecule(Lys-Thr-Thr-Lys-Ser) corresponding with the protein base of collagen; the soybean embryo isoflavone aglycon is selected from genistin, daidzin, glycitin, genistein, daidzein and glycitein; and the amounts of palmitoylpentapeptide, soybean embryo isoflavone aglycon, extract of Medicago sativa and extract of Iris florenti are 0.001-20 wt.%, 0.001-20 wt.%, 0.001-20 wt.% and 0.001-20 wt.%, respectively.
Abstract translation: 提供皮肤外用组合物以增加皮肤中托普弹力素的产生，以及真皮层中胶原和纤维蛋白的产生，使得该组合物可用于皮肤皱纹改善，皮肤弹性增强和皮肤保湿增加。 用于改善皮肤皱纹，增强皮肤弹性和增加皮肤保湿的皮肤外用组合物包括含有棕榈酰五肽，大豆胚异黄酮糖苷配基，苜蓿提取物和鸢尾花提取物的混合物，其中棕榈酰五肽通过将棕榈酰基结合到5个氨基 对应于胶原蛋白质的酸链分子（Lys-Thr-Thr-Lys-Ser） 大豆胚异黄酮糖苷配基选自染料木苷，黄豆苷苷，大豆蛋白，染料木素，黄豆苷原和黄豆黄素; 棕榈酰五肽，大豆胚异黄酮糖苷配基，苜蓿提取物和鸢尾花提取物的量分别为0.001-20重量％，0.001-20重量％，0.001-20重量％和0.001-20重量％ 。
-
Patent Agency Ranking36.发明公开2-(3,4-다이플루오로페닐)-3-프로필-2-사이클로펜텐-1-온옥심을 유효성분으로 함유하는 피부노화 및 주름 방지용 화장료 조성물 有权包含具有抗衰老和抗皱效果的2-（3,4-二氟苯基）-3-丙炔-2-环戊烯-1-酮氧化物的化妆品组合物
公开(公告)号：KR1020060091724A
公开(公告)日：2006-08-21
申请号：KR1020050012528
申请日：2005-02-16
Applicant: (주)아모레퍼시픽
Abstract: 본 발명은 2-(3,4-다이플루오로페닐)-3-프로필-2-사이클로펜텐-1-온 옥심 또는 허용가능한 그의 염을 유효성분으로 함유하는 피부노화 및 주름 방지용 화장료 조성물에 관한 것으로, 본 발명의 화장료 조성물은 피부내 염증을 억제하는 2-(3,4-다이플루오로페닐)-3-프로필-2-사이클로펜텐-1-온 옥심을 유효성분으로 함유하여 피부노화 및 주름 방지에 효과적으로 사용될 수 있다.
-
-
-
公开(公告)号：KR101766393B1
公开(公告)日：2017-08-10
申请号：KR1020100120370
申请日：2010-11-30
Applicant: (주)아모레퍼시픽
CPC classification number: G01N33/573 , G01N2333/96466 , G01N2800/20
Abstract: 본발명은건조피부개선물질을스크리닝하는방법으로서, 후보물질에의한블레오마이신하이드로라제(Bleomycin hydolase: 이하BH)의유전자발현변화량에기초하여스크리닝하는것을특징으로하는건조피부개선물질을스크리닝하는방법을제공하고, 스크리닝으로찾아낸건조피부개선물질을제공한다. 또한 BH 유전자발현량을증가시키는 LXR 활성화제를유효성분으로함유하는피부외용제조성물을제공한다. 본발명의스크리닝방법은효과적인건조피부개선물질을찾을수 있게하는효과가있고, 상기조성물은건조한피부를개선시키고, 피부의수분손실을방지하여서, 피부각질층의피부장벽을회복시키는효과가있다.
-
公开(公告)号：KR1020160117015A
公开(公告)日：2016-10-10
申请号：KR1020150045560
申请日：2015-03-31
Applicant: (주)아모레퍼시픽
IPC: A61K31/704 , A61K8/60 , A61Q19/00
CPC classification number: A61K31/704 , A61K8/60 , A61Q19/00
Abstract: 본발명은진세노사이드 Rg1을유효성분으로함유하고, 상기진세노사이드 Rg1은서리아신을억제하는것을특징으로하는피부외용제조성물에관한것이다. 본발명에따른피부외용제조성물은피부질환예방및 경감용또는피부보습용으로사용될수 있다. 이때, 상기피부질환은아토피또는건선을포함한다. 본발명의피부외용제조성물은서리아신이유발하는피부각질세포형성의이상현상을저지할수 있으며, 이에따라피부질환을예방또는경감할수 있고, 피부수분함유량을향상시킬수 있다.
-
-
-
-
-
-
-
-
-
Search Results
77
records
(took 0.032 seconds)
